Quantcast

Latest Pfizer Stories

2014-04-27 23:00:42

The Firm is actively evaluating Lipitor lawsuit claims on behalf of individuals who allege their use of the cholesterol-lowering medication caused them to develop Type 2 diabetes. New York, New York (PRWEB) April 27, 2014 In just over a month, nearly 200 new Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) have been filed in a federal litigation underway in the U.S. District Court, District of South Carolina on behalf of individuals who allegedly developed Type 2 diabetes due to...

2014-04-25 20:21:31

Mylan Seeks to Confirm Shared 180-Day Exclusivity PITTSBURGH, April 25, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has filed suit against the U.S. Food and Drug Administration (FDA), challenging the agency's decision regarding generic drug marketing exclusivity on Celecoxib Capsules, the generic version of Pfizer's Celebrex(®). FDA issued a decision holding that eligibility for 180 days of exclusivity is only available to an applicant who first filed a...

2014-04-25 08:28:05

ROCKLAND, Mass., April 25, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66(th )Annual Meeting, taking place from April 26 - May 3, in Philadelphia, PA. http://photos.prnewswire.com/prnvar/20121220/SF32295LOGO-b Data from 14 study assessments presented by EMD Serono or its affiliate, Merck Serono, the...

2014-04-25 08:25:00

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 25, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Allergan, Inc. (NYSE: AGN), Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Actavis plc (NYSE: ACT) and Express Scripts Holding Company (NASDAQ: ESRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available...

2014-04-24 23:00:57

The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) April 24, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that allege the popular statin drugs caused some patients to develop Type 2 diabetes continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina. According to court documents, the...

2014-04-24 12:30:28

The Majority of Non-Prescribers Anticipate Prescribing Gilotrif Within the Next Three Months, According to Findings from Decision Resources Group BURLINGTON, Mass., April 24, 2014 /PRNewswire/ -- Decision Resources Group finds that at six months post-launch in the United States, 49 percent of surveyed U.S. medical oncologists have prescribed Boehringer Ingelheim's irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Gilotrif, for NSCLC patients outside of...

2014-04-24 08:36:01

DUBLIN, April 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Pfizer, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Celebrex(® )(celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules. Celebrex(®) is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults. Under the terms...

2014-04-23 16:30:09

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3mgfnj/acute) has announced the addition of the "Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in G8 Countries (2011 - 2020)" [http://www.researchandmarkets.com/research/3mgfnj/acute ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The acute...

2014-04-21 16:25:13

NEW YORK, April 21, 2014 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) announces a $190 Million settlement, subject to court approval, with Pfizer, Inc. and Warner-Lambert Co. ("Defendants") in In re Neurontin Antitrust Litigation, No. 02-1390, pending in the District of New Jersey. Kaplan Fox serves as one of two co-lead counsel representing a class of direct purchasers of Neurontin from Defendants between December 11, 2002 and August 31, 2008 and who...

2014-04-17 23:04:30

Dallas Mavericks owner funds new 2-year HGH study. Miami, FL (PRWEB) April 17, 2014 AAG Health, the leader in integrative wellness, is excited to throw its support behind Dallas Mavericks owner Mark Cuban, who recently funded a university study about human growth hormone. Cuban, who has brought up the topic of HGH at past NBA Board of Governors’ meetings, sees the hormone as a potential way for injured athletes to recover faster, according to an April 4 ESPN Dallas article. His hope is...


Latest Pfizer Reference Libraries

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (2 articles) »
Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related